INS and cancer: Besides, because of the small number of patients we could not take into account the dose of insulin, in spite of the fact that we were aware that the possibility of association between cancer and higher glargine doses suggests that dosages should always be considered when assessing the possible association of insulin and its analogues with cancer[19].